NYSE Arca approves the ProShares Ultra XRP ETF (UXRP), which targets 2x daily XRP futures returns. UXRP avoids direct XRP ...

The SEC delays its decision on in-kind creations for Bitwise Bitcoin and Ethereum ETFs, extending the review period to ...

The new futures-based ETFs aim to deliver 2x daily returns on SOL and XRP as spot ETF proposals await SEC decisions, ...

With markets still volatile, keep your portfolio protected with high-yielding exchange-traded funds. Look at the Amplify CWP ...

ProShares introduces futures XRP ETF and SOL ETF designed to deliver 2x the daily performance of SOL and XRP, targeting ...

The ProShares Ultra XRP ETF is expected to start trading on NYSE Arca from July 18. XRP broke above $2.92 following the ...

XRP price has surged nearly 30% over the past week and is eyeing a breakout past the $3.0 resistance amid rising investor ...

ProShares Ultra XRP ETF receives NYSE Arca approval, offering leveraged 2x daily exposure to XRP price via futures-based ...

The US SEC has officially approved the ProShares Ultra XRP ETF, and it is set to launch on the NYSE Arca this week.

The Dow advanced 231.49 points (0.5%) to 44,254.78, the Nasdaq rose 52.69 points (0.3%) to 20,730.49 and the S&P 500 climbed 19.94 points (0.3%) to 6,263.70.

A generous grace period would give drugmakers time to sidestep most of the pain of looming duties.